High-Dose Cyclophosphamide Followed by Autografting Can Improve the Outcome of Relapsed or Resistant Non-Hodgkin's Lymphomas with Involved or Hypoplastic Bone Marrow

References

• Gordon L. I., Harrington D., Andersen J., et al. Comparison of a second‐generation combination chemother‐apeutic regimen (m‐BACOD) with a standard regimen (CHOP) for advanced diffuse non‐Hodgkin's lymphoma. N. Engl. J. Med. 1992; 327: 1342–1349
   PubMed Web of Science ®Google Scholar
• Fisher R. I., Gaynor E. R., Dahlberg S., et al. Comparison of standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non‐Hodgkin's lymphoma. N. Engl. J. Med. 1993; 328: 1002–1006
   PubMed Web of Science ®Google Scholar
• Sertoli M. R., Santini G., Chisesi T., et al. MACOP‐B vs ProMACE‐MOPP in the treatment of advanced diffuse non‐Hodgkin's Lymphoma: results of a prospective randomized trial by the Non‐Hodgkin's Lymphoma Cooperative Study Group. J. Clin. Oncol. 1994; 12: 1366–1374
   PubMed Web of Science ®Google Scholar
• Cabanillas F., Hagemeister F. B., Mc Laughlin P., et al. Results of MIME salvage regimen for recurrent or refractory lymphoma. J. Clin. Oncol. 1987; 5: 407–410
   PubMed Web of Science ®Google Scholar
• Velasquez W. S., Cabanillas F., Salvador P., et al. Effective salvage therapy for lymphoma with cisplatin in combination with high‐dose Ara‐C and dexamethasone (DHAP). Blood 1988; 71: 117–122
   PubMed Web of Science ®Google Scholar
• Velasquez W. S., McLaughlin P., Tucker S., et al. ESHAP‐an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4‐year follow‐up study. J. Clin. Oncol. 1994; 12: 1169–1176
   PubMed Web of Science ®Google Scholar
• Philip T., Armitage J. O., Spitzer G., et al. High‐dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate‐grade or high‐grade non‐Hodgkin's lymphoma. N. Engl. J. Med. 1987; 316: 1493–1497
   PubMed Web of Science ®Google Scholar
• Gribben J. G., Goldstone A. H., Linch D. C., et al. Effectiveness of high‐dose combination chemotherapy and autologous bone marrow transplantation for patients with non‐Hodgkin's lymphomas who are still responsive to conventional‐dose therapy. J. Clin. Oncol. 1989; 7: 1621–1629
   PubMed Web of Science ®Google Scholar
• Mills W., Chopra R., McMillan A., et al. BEAM chemotherapy and autologous bone marrow transplantation for patients with non‐Hodgkin's lymphoma. J. Clin. Oncol. 1995; 13: 588–595
   PubMed Web of Science ®Google Scholar
• Philip T., Guglielmi C., Hagenbeek A., et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy‐sensitive non‐Hodgkin's lymphoma. N. Engl. J. Med. 1995; 333: 1540–1545
   PubMed Web of Science ®Google Scholar
• Kessinger A., Armitage J. O., Smith D. M., et al. High‐dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. Blood 1989; 74: 1260–1264
   PubMed Web of Science ®Google Scholar
• Korbling M., Holle R., Haas R., et al. Autologous blood stem cell transplantation in patients with advanced Hodgkin's disease and prior radiation to the pelvic site. J. Clin. Oncol. 1990; 8: 978–987
   PubMed Web of Science ®Google Scholar
• Williams S. F., Bitran J. D., Richards J. M., et al. Peripheral blood derived stem cell collection for use in autologous transplantation after high dose chemotherapy: an alternative approach. Bone Marrow Transplant. 1990; 5: 129–133
   PubMed Web of Science ®Google Scholar
• Dreyfus F., Leblond V., Belander C., et al. Peripheral blood stem cell collection and autografting in high risk lymphomas. Bone Marrow Transplant. 1992; 10: 409–413
   PubMed Web of Science ®Google Scholar
• Santini G., Congiu A. M., Nati S., et al. Mobilization/transplantation of peripheral blood progenitor cells for aggressive non‐Hodgkin's lymphoma with marrow involvement. Leukemia 1996; 10(Suppl 2)S88–S91
   PubMedGoogle Scholar
• Hardinghan J. E., Kotasek D., Sage R. E., et al. Molecular detection of residual lymphoma cells in peripheral blood stem cells harvests and following autologous transplantation. Bone Marrow Transplant. 1993; 11: 15–20
   PubMed Web of Science ®Google Scholar
• Tarella C., Ferrero D., Bregni M., et al. Peripheral blood expansion of early progenitor cells after high‐dose cyclophosphamide and rhGM‐CSF. Eur. J. Cancer 1991; 27: 22–27
   PubMed Web of Science ®Google Scholar
• Goldschmidt H., Hegenbart U., Haas R., Hunstein W. Mobilization of peripheral blood progenitor cells with high‐dose cyclophosphamide (4 or 7 g/m2) and granulocyte colony‐stimulating factor in patients with multiple myeloma. Bone Marrow Transplant. 1996; 17: 691–697
   PubMed Web of Science ®Google Scholar
• National Cancer Institute sponsored study of classification of non‐Hodgkin's lymphoma:. Summary and description of a working formulation for clinical use. Cancer 1982; 49: 2112–2135
   PubMed Web of Science ®Google Scholar
• Wilson W., Magrath I. Principles of chemotherapy. The non‐Hodgkin's lymphomas, I. T. Magrath. Willians & Wilkins Publishers, Baltimore, Hong Kong, London, Sydney 1990; 200–213
   Google Scholar
• O'Reilly S. E., Hoskins P., Klimo P., Connors J. M. MACOP‐B and VACOP‐B in diffuse large cell lymphomas and MOPP/ABV in Hodgkin's disease. Ann. Oncol. 1991; 2(suppl 1)17–23
   PubMedGoogle Scholar
• Siena S., Bregni M., Brando B., et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991; 77: 400–409
   PubMed Web of Science ®Google Scholar
• Kaplan E. L., Meier P. Non parametric estimation from incomplete observation. J. Am. Stat. Assoc. 1958; 53: 457–481
   Web of Science ®Google Scholar
• Cox D. R. Regression models and life tables. J. R. Stat. Soc. 1972; 34: 187–220
   Google Scholar
• De Vita V. T., Jaffe E. S., Mauch P., Longo D. L. Lymphocytic lymphomas. Cancer: Principles and Practice of Oncology, V. T. De Vita, S. Hellman, S. A. Rosenberg. Lippincott Publishers, Philadelphia 1989; 1741–1808
   Google Scholar
• Kotasek D., Shephered K. M., Sage R. E., et al. Factors affecting blood stem cell collections following high‐dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumours. Bone Marrow Transplant. 1992; 9: 11–18
   PubMed Web of Science ®Google Scholar
• To L. B., Haylock D. N., Simmons P. J., Juttner C. A. The biology and clinical uses of blood stem cells. Blood 1997; 89: 2233–2258
   PubMed Web of Science ®Google Scholar